Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$102.9M
Filings
686
Firms Hired
14
Active Period
2004–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Methane Waste Prevention Act of 2021
2026 · third_quarter · Firm: THE MCMANUS GROUP
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs, including Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299). Support for H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1492
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs, including Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299). Support for H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4299
Inflation Reduction Act of 2022
2026 · third_quarter · Firm: W STRATEGIES, LLC
Implementation H.R.5376 - Inflation Reduction Act of 2022. Issues around drug pricing.
Client expense: — · Firm income: $60,000
Matched citations: H.R.5376
Impacts and Outcomes for Health Career Training Act
2026 · second_quarter · Firm: W STRATEGIES, LLC
Implementation H.R.5376 - Inflation Reduction Act of 2022. Public Law 119-21: One Big Beautiful Bill Act. Issues around drug pricing.
Client expense: — · Firm income: $60,000
Matched citations: H.R.5376
Methane Waste Prevention Act of 2021
2026 · second_quarter · Firm: THE MCMANUS GROUP
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs, including Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299). Support for H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1492
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs, including Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299). Support for H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4299
Methane Waste Prevention Act of 2021
2026 · first_quarter · Firm: THE MCMANUS GROUP
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs, including Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299). Support for H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1492
Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to physician reimbursement for Part B drugs, including Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299). Support for H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4299
Impacts and Outcomes for Health Career Training Act
2026 · first_quarter · Firm: W STRATEGIES, LLC
Implementation H.R.5376 - Inflation Reduction Act of 2022. Public Law 119-21: One Big Beautiful Bill Act. Issues around drug pricing.
Client expense: — · Firm income: $60,000
Matched citations: H.R.5376
Impacts and Outcomes for Health Career Training Act
2025 · fourth_quarter · Firm: W STRATEGIES, LLC
Implementation H.R.5376 - Inflation Reduction Act of 2022. Public Law 119-21: One Big Beautiful Bill Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R.5376
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2025 · fourth_quarter · Firm: THE MCMANUS GROUP
Support for EPIC Act - S. 832, and H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1492
Support for EPIC Act - S. 832, and H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model.
Client expense: — · Firm income: $60,000
Matched citations: S. 832
Medical Supply Chain Resiliency Act
2025 · fourth_quarter · Firm: TIBER CREEK GROUP
Issues related to international trade; Issues related to intellectual property protections for COVID-19 treatments; Issues related to the TRIPS Waiver; Global supply chain issues, including H.R. 2213/S. 998 - Medical Supply Chain Resiliency Act; Issues related to compulsory licensing and other intellectual property issues in multiple countries.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2213
Medical Supply Chain Resiliency Act
2025 · fourth_quarter · Firm: TIBER CREEK GROUP
Issues related to international trade; Issues related to intellectual property protections for COVID-19 treatments; Issues related to the TRIPS Waiver; Global supply chain issues, including H.R. 2213/S. 998 - Medical Supply Chain Resiliency Act; Issues related to compulsory licensing and other intellectual property issues in multiple countries.
Client expense: — · Firm income: $60,000
Matched citations: S. 998
Medical Supply Chain Resiliency Act
2025 · third_quarter · Firm: TIBER CREEK GROUP
Issues related to international trade; Issues related to intellectual property protections for COVID-19 treatments; Issues related to the TRIPS Waiver; Global supply chain issues, including H.R. 2213/S. 998 - Medical Supply Chain Resiliency Act; Issues related to compulsory licensing and other intellectual property issues in multiple countries.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2213
Medical Supply Chain Resiliency Act
2025 · third_quarter · Firm: TIBER CREEK GROUP
Issues related to international trade; Issues related to intellectual property protections for COVID-19 treatments; Issues related to the TRIPS Waiver; Global supply chain issues, including H.R. 2213/S. 998 - Medical Supply Chain Resiliency Act; Issues related to compulsory licensing and other intellectual property issues in multiple countries.
Client expense: — · Firm income: $60,000
Matched citations: S. 998
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2025 · third_quarter · Firm: THE MCMANUS GROUP
Support for EPIC Act - S. 839, and H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1492
Support for EPIC Act - S. 839, and H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model.
Client expense: — · Firm income: $60,000
Matched citations: S. 839
Impacts and Outcomes for Health Career Training Act
2025 · third_quarter · Firm: W STRATEGIES, LLC
Implementation H.R.5376 - Inflation Reduction Act of 2022. Public Law 119-21: One Big Beautiful Bill Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R.5376
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
2025 · second_quarter · Firm: THE MCMANUS GROUP
Support for EPIC Act - S. 839, and H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1492
Support for EPIC Act - S. 839, and H.R. 1492, To equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Policies related to the Most Favored Nation Drug Pricing Model
Client expense: — · Firm income: $60,000
Matched citations: S. 839
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: CAPITOL TAX PARTNERS, LLP
Legislative services related to corporate and international tax matters and H.R. 1, 2025 Budget Reconciliation Bill.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1
H.R.1492 - EPIC Act. Implementation H.R.5376 - Inflation Reduction Act of 2022. H.R.1 - One Big Beautiful Bill Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1
Methane Waste Prevention Act of 2021
2025 · second_quarter · Firm: W STRATEGIES, LLC
H.R.1492 - EPIC Act. Implementation H.R.5376 - Inflation Reduction Act of 2022. H.R.1 - One Big Beautiful Bill Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1492
Inflation Reduction Act of 2022
2025 · second_quarter · Firm: W STRATEGIES, LLC
H.R.1492 - EPIC Act. Implementation H.R.5376 - Inflation Reduction Act of 2022. H.R.1 - One Big Beautiful Bill Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R.5376
Source: Senate LDA